0.38
-0.0199(-4.94%)
Currency In USD
| Previous Close | 0.4 |
| Open | 0.41 |
| Day High | 0.41 |
| Day Low | 0.36 |
| 52-Week High | 1.32 |
| 52-Week Low | 0.28 |
| Volume | 366,677 |
| Average Volume | 884,660 |
| Market Cap | 10.43M |
| PE | -0.5 |
| EPS | -0.77 |
| Moving Average 50 Days | 0.47 |
| Moving Average 200 Days | 0.65 |
| Change | -0.02 |
If you invested $1000 in Cosmos Health Inc. (COSM) 10 years ago, it would be worth $1,877.45 as of March 04, 2026 at a share price of $0.383. Whereas If you bought $1000 worth of Cosmos Health Inc. (COSM) shares 5 years ago, it would be worth $3.61 as of March 04, 2026 at a share price of $0.383.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board
GlobeNewswire Inc.
Feb 24, 2026 5:30 PM GMT
CHICAGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the appointment of Dr. Dimitrios Iliopoulos to its Advisor
Cosmos Health Highlights Approximately $15 Million Fair Market Value of Real Estate Assets, Exceeding Current Market Capitalization; Evaluates Monetization Options to Address Significant Discount to Book Value
GlobeNewswire Inc.
Feb 19, 2026 4:30 PM GMT
CHICAGO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today highlighted the intrinsic value of its wholly owned real estate port
Cosmos Health Continues UK Retail Expansion for C-Scrub; Now Available at Superdrug, the UK’s Second-Largest Beauty and Health Retailer
GlobeNewswire Inc.
Feb 18, 2026 6:45 PM GMT
CHICAGO, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced continued expansion of its United Kingdom (UK) retail foot